These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3129309)

  • 1. Single amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme.
    Barthélémy M; Péduzzi J; Ben Yaghlane H; Labia R
    FEBS Lett; 1988 Apr; 231(1):217-20. PubMed ID: 3129309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling.
    Huletsky A; Knox JR; Levesque RC
    J Biol Chem; 1993 Feb; 268(5):3690-7. PubMed ID: 8429044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.
    Bradford PA; Urban C; Jaiswal A; Mariano N; Rasmussen BA; Projan SJ; Rahal JJ; Bush K
    Antimicrob Agents Chemother; 1995 Apr; 39(4):899-905. PubMed ID: 7785992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase.
    Péduzzi J; Barthélémy M; Tiwari K; Mattioni D; Labia R
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2160-3. PubMed ID: 2694955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of a new plasmid-encoded SHV-type beta-lactamase (SHV-2 variant) conferring high-level cefotaxime resistance upon Klebsiella pneumoniae.
    Podbielski A; Schönling J; Melzer B; Warnatz K; Leusch HG
    J Gen Microbiol; 1991 Mar; 137(3):569-78. PubMed ID: 2033379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new SHV-derived extended-spectrum beta-lactamase (SHV-24) that hydrolyzes ceftazidime through a single-amino-acid substitution (D179G) in the -loop.
    Kurokawa H; Yagi T; Shibata N; Shibayama K; Kamachi K; Arakawa Y
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1725-7. PubMed ID: 10817740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime-hydrolysing activity of the beta-lactamase of Klebsiella oxytoca D488 could be related to a threonine residue at position 140.
    Reynaud A; Péduzzi J; Barthélémy M; Labia R
    FEMS Microbiol Lett; 1991 Jun; 65(2):185-92. PubMed ID: 1909282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of the SHV-11 beta-lactamase of Shigella dysenteriae.
    Ahamed J; Kundu M
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2081-3. PubMed ID: 10428943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Asp104 in the SHV beta-lactamase.
    Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel SHV beta-lactamase variant that resembles the SHV-5 enzyme.
    Prinarakis EE; Tzelepi E; Gazouli M; Mentis AF; Tzouvelekis LS
    FEMS Microbiol Lett; 1996 Jun; 139(2-3):229-34. PubMed ID: 8674992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHV-27, a novel cefotaxime-hydrolysing beta-lactamase, identified in Klebsiella pneumoniae isolates from a Brazilian hospital.
    Corkill JE; Cuevas LE; Gurgel RQ; Greensill J; Hart CA
    J Antimicrob Chemother; 2001 Apr; 47(4):463-5. PubMed ID: 11266422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and amino acid sequence analysis of a new oxyimino cephalosporin-hydrolyzing class A beta-lactamase from Serratia fonticola CUV.
    Péduzzi J; Farzaneh S; Reynaud A; Barthélémy M; Labia R
    Biochim Biophys Acta; 1997 Aug; 1341(1):58-70. PubMed ID: 9300809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain.
    Sabaté M; Tarragó R; Navarro F; Miró E; Vergés C; Barbé J; Prats G
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1970-3. PubMed ID: 10858363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tazobactam inactivation of SHV-1 and the inhibitor-resistant Ser130 -->Gly SHV-1 beta-lactamase: insights into the mechanism of inhibition.
    Pagan-Rodriguez D; Zhou X; Simmons R; Bethel CR; Hujer AM; Helfand MS; Jin Z; Guo B; Anderson VE; Ng LM; Bonomo RA
    J Biol Chem; 2004 May; 279(19):19494-501. PubMed ID: 14757767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close amino acid sequence relationship between the new plasmid-mediated extended-spectrum beta-lactamase MEN-1 and chromosomally encoded enzymes of Klebsiella oxytoca.
    Barthélémy M; Péduzzi J; Bernard H; Tancrède C; Labia R
    Biochim Biophys Acta; 1992 Jul; 1122(1):15-22. PubMed ID: 1633193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different promoters of SHV-2 and SHV-2a beta-lactamase lead to diverse levels of cefotaxime resistance in their bacterial producers.
    Podbielski A; Schönling J; Melzer B; Haase G
    J Gen Microbiol; 1991 Jul; 137(7):1667-75. PubMed ID: 1955859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.
    Prinarakis EE; Miriagou V; Tzelepi E; Gazouli M; Tzouvelekis LS
    Antimicrob Agents Chemother; 1997 Apr; 41(4):838-40. PubMed ID: 9087500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
    Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
    J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.